E, C. A., T, M. A., Z, T. M., & T, A. D. (2021). Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target. Dove Medical Press.
Cita Chicago Style (17a ed.)E, Chekol Abebe, Mengie Ayele T, Tilahun Muche Z, y Asmamaw Dejenie T. Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target. Dove Medical Press, 2021.
Cita MLA (8a ed.)E, Chekol Abebe, et al. Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.